Director/PDMR Shareholding
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Bassam Kanaan |
2 | Reason for the notification | |
a) | Position/status | Chief Strategy and Corporate Development Officer |
b) | Initial notification /Amendment | Initial notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | Name | Hikma Pharmaceuticals PLC |
b) | LEI | 549300BNS685UXH4JI75 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083 |
b) | Nature of the transaction
| Disposal of 30,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. |
c) | Price(s) and volume(s) | Price(s): £19.17 Volume(s): 30,000 |
d) | Aggregated information | Aggregated volume: 30,000 Price: £575,100 |
e) | Date of the transaction | 20 to 21 August 2018 |
f) | Place of the transaction | London Stock Exchange (XLON) |
Peter Speirs, Company Secretary, Responsible for releasing this announcement
22 August 2018
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.